Posts by Sandra Ansanay-Alex
Gaia Tech AG raises CHF 480,000
The Bern-based start-up extracts natural antioxidants from agricultural waste and has successfully closed its pre-seed funding round with SICTIC business angels, Venture Kick, and the Stiftung für technologische Innovation STI. Gaia Tech emerged from an innovative research project at the ETH Zürich. The ETH Spin-off company develops technologies that can unlock and market valuable resources found in…
Read MoreEpiterna raised €10 Million
The longetivity start-up, based at Biopôle, is funded by Prima Materia, the investment firm founded by Spotify founder Daniel Ek and early Spotify backer Shakil Khan. EPITERNA was founded in 2022 to help pets and people live longer and healthier lives. The start-up, founded by Alejandro Ocampo. and Kevin Perez, now employs about 15…
Read MoreMRA between Switzerland and the USA in the area of Good Manufacturing Practice for medicinal products takes effect
The Mutual Recognition Agreement (MRA) between Switzerland and the United States in the area of Good Manufacturing Practice for medicinal products signed in January 2023 has entered into force with effect from 27 July 2023. In principle each country thus accepts the inspections carried out by the other’s regulatory authority (Swissmedic or FDA). The…
Read MoreMedicxi announces a $400m fund for life sciences projects
Medicxi, a leading European life sciences investment firm, announces its $400 million Medicxi IV fund. The new fund will continue to support drug hunters with clear product visions to deliver transformative therapies for patients. Medicxi’s investments have resulted in the development of several marketed and late-stage development drugs, including Daratumumab (Genmab/Johnson & Johnson),…
Read MoreCHUV: a child on bi-ventricular cardiac assistance could be weaned off the machine and avoid a heart transplant
After spending a year in the Pediatric Intensive Care Unit at CHUV, a 4-year-old boy did not need a heart transplant in the end: his heart now beats “on its own”. Multidisciplinary care made it possible to carry out this technical and risky operation, never before attempted at the CHUV. This patient’s story is…
Read MoreGivaudan expands its Protein Hub in Zurich to create dairy alternatives
Geneva-based Givaudan has expanded the Protein Hub at its flagship Zurich Innovation Centre in Kemptthal, to support the growth of dairy alternatives. The expanded Hub offers specialised expertise, state-of-the-art digital technologies, and an integrated portfolio of solutions designed specifically for dairy alternatives to accelerate new product development and co-create exciting new food experiences in collaboration…
Read MoreSulfiscon and biped.ai recipients of the Biopôle Start-up Fund
The fund offers up to CHF 90,000 a year, over three consecutive years, to promising life sciences ventures. Sulfiscon develops small molecule allosteric modulators that can be administered as drugs to treat pathological calcification disorders. Pathological calcification can affect different organs and is associated with ageing and diseases. At present, surgery is the…
Read MorePeriVision raises between CHF 0.5 and 1 Million in a Seed Round
PeriVision is utilizing the power of artificial intelligence (AI), virtual reality (VR), and cloud computing to redefine eye testing and care. Perivision, a University of Bern spin-off now located at Biopôle, is developing a portfolio of virtual eye tests conducted on commercial VR headsets. Doctors can easily configure and analyze the test results on…
Read MoreA patient in remission from HIV after a bone marrow transplant
The HUG and the Institut Pasteur have announced an exceptional case of HIV remission. A promising discovery. The patient has been living with HIV since the early 1990s and has always been on antiretroviral treatment. In 2018, to treat a particularly aggressive form of leukaemia, he underwent a stem cell transplant. One month after…
Read MoreCERN Venture Connect
The CERN Venture Connect (CVC) programme aims to act as a connector to bring together great entrepreneurs, provide them with cutting edge technologies and connect them to investors and incubators who can help them succeed. Why apply to CVC? Curated state-of-art technologies Network of venture capitalists, incubators, mentors and service provider A bridge…
Read More